Forty-four patients with small cell lung cancer were treated with an intensive chemotherapy
induction program consisting of combination cyclophosphamide, Adriamycin, and vincristine …

The Southwest Oncology Group (SWOG) has conducted a phase II study to explore the
efficacy and toxicity of initial, concurrent use of radiation therapy with cisplatin, etoposide …

Abstract SIXTY-TWO PATIENTS with previously untreated limited stage small cell lung
cancer were treated in a prospectively randomized trial comparing thoracic irradiation plus …

PURPOSE The primary objective of this randomized prospective study was to compare the
survival of limited-stage small-cell lung cancer (SCLC) patients treated with chemotherapy …

This study investigated the use of late dose intensification therapy (LDIT) with
cyclophosphamide (180 mg/kg) and VP 16 (1 g/m 2) plus autologous bone marrow rescue in …

In a pilot study, 21 consecutive eligible patients with extensive-stage small cell carcinoma of
the lung were scheduled for treatment with combination chemotherapy followed by total …

One hundred forty-seven eligible patients with small-cell carcinoma of the lung (SCCL) have
been randomized to receive alternating (A) or sequential (S) combination chemotherapy …

In 1979 we initiated a phase III study in the Southwest Oncology Group (SWOG) which was
designed to determine the value of chest radiation in limited-stage small-cell lung cancer …

Between March 1986 and May 1988, the Southwest Oncology Group enrolled 58 previously
untreated patients with limited small-cell lung cancer on a treatment program that …

Fifty-six patients with small cell carcinoma of the lung were treated with a two-cycle induction
course of hexamethylmelamine, vincristine, doxorubicin, and cyclophosphamide. Patients …